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Objectives. To evaluate and compare the complication rate of sedation with or without propofol regimen for percutaneous
endoscopic gastrostomy (PEG) in a hospital in Thailand. Subjects and Methods. A total of 198 patients underwent PEG procedures
by using intravenous sedation (IVS) from Siriraj Hospital, Thailand from August 2006 to January 2009. The primary outcome
variable was the overall complication rate. The secondary outcome variables were sedation and procedure related complications,
and mortality rate. Results. After matching ASA physical status and indications of procedure, there were 92 PEG procedures in
propofol based sedation group (A) and 20 PEG procedures in non-propofol based sedation group (B). All sedation was given
by residents or anesthetic nurses directly supervised by staﬀ anesthesiologist in the endoscopy room. There were no signiﬁcant
diﬀerences in patients’ characteristics, sedation time, indication, complications, anesthetic personnel and mortality rate between
the two groups. All complications were easily treated, with no adverse sequelae. Mean dose of fentanyl and midazolam in group A
was signiﬁcantly lower than in group B. Conclusion. Propofol-based sedation does not increase rate of complication during PEG
procedure. Additionally, IVS of PEG procedure is relatively safe and eﬀective when performed by physicians in training. Serious
complications are none.
1.Introduction
Percutaneous endoscopic gastrostomy (PEG) has become
the procedure of choice for enteral feedings in patients
with a functioning gastrointestinal tract who need long-
term enteral feeding, when oral access is impossible [1,
2]. PEG has replaced the surgical gastrostomy procedure
because of its lower cost and shorter recovery time. Many
patientsrequiringPEGareolder,frail,andmalnourishedand
have a signiﬁcant comorbidity. PEG insertion is an invasive
procedure requiring both endoscopy and sedation. It usually
carriesariskofhighmortalityratesintheearlypostinsertion
period, with 30-day mortality rates varying between 4%
and 26% [3]. Furthermore, there is a substantial risk of
morbidity, especially from sedation and/or anesthesia [4].
Anesthesia consultation before the procedure is needed.
Fluid and electrolyte disorders should be corrected and any
infection treated. Antibiotic prophylaxis is recommended
due to the infection risks. Ideally, PEG should be performed
in an operating room. In practice, however, most proce-
dures are performed in the endoscopy room, with special
precautions.Thetypeofanesthesiausedisdecidedaccording
to the patient’s medical condition and the anesthesiologist’s
preference. Intravenous sedation (IVS) can be used, but
to assure better patient comfort during this complicated
procedure, short-term deep sedation is preferred.
We conducted a retrospective study to discover whether
there is a diﬀerence in the incidence of complication rate
between patients who received PEG procedure with or
without propofol-based sedation and to evaluate the safety
of IVS when sedated by anesthetic personnel from the World
Gastroenterology Organization (WGO) Endoscopy Training
Center in Thailand.
2.MaterialsandMethod
2.1. Patients. A total of 279 consecutive patients from
Siriraj Hospital, Bangkok, Thailand who underwent PEG2 Gastroenterology Research and Practice
procedures from August 2006 to January 2009 were eligible
for the study. Of these, 198 patients underwent PEG
procedures by using intravenous sedation (IVS). Inclusion
criteria were age ≥18 and PEG procedures performed using
IVS technique. Exclusion criteria were patients younger
than 18 years, procedures performed in the intensive care
units,proceduresperformedwithoutsedation,orprocedures
performed under monitored anesthesia care and general
anesthesia.
2.2. Study Design. This study is a retrospective descriptive
study. All patients were classiﬁed into two groups according
to the type of IVS technique. In group A, PEG was done
by using propofol-based IVS technique. In group B, PEG
was performed with non-propofol-based IVS technique.
The primary outcome variable of the study was the overall
complication rate during and immediately after procedure.
The secondary outcome variables were sedation- and pro-
cedure related complications during and immediately after
procedure and mortality rate.
2.3. Assessment of Complication Rate. After PEG procedure,
all patients were observed in the recovery room at least
two hours before discharged to ward. Additionally, all
patients were admitted in the ward to rule out post-PEG
complications at least one day after the procedure. We did
not call each patient at the thirtieth day after the procedure.
Overall complication rate in both groups was recorded.
Additionally, sedation- and procedure related complication
and mortality rate in the two groups were also assessed.
2.4. Sedation-Related Complications. All Sedation-related
complications were recorded. Sedation-related complica-
tions were deﬁned as follows: hypertension or hypotension
(increase or decrease in blood pressure by 20% from
baseline and above or below normal for age); tachycardia or
bradycardia (increase or decrease in heart rate by 20% from
baseline and above or below normal for age); any cardiac
arrhythmias; hypoxia (oxygen desaturation, SpO2 < 90%);
airway obstruction.
2.5. Procedure Related Complications. Procedure related
complications during and early post procedure such as
bleeding,lacerationorpunctureofvisceralorgans,andPEG-
site infection were recorded. We did not assess the late
complications.
2.6. Statistical Analysis. Results were expressed as mean ±
SD or percentage (%), when appropriate. Comparisons
between group A and B weredone by using Chi-square tests
(for categorical variables), Chi-square tests for trend (for
ordinal variables), and two-sample independent t-test (for
continuous variables). The statistical software package SPSS
for Window Version 11 (SPSS Inc., Chicago, IL) was used to
analyze the data. All statistical comparisons were made at the
two-sided 5% level of signiﬁcance.
3. Results
Two hundred and seventy-nine PEG procedures were per-
formed during the study period. Of these, 81 patients
who underwent PEG procedure by using general anesthesia
and monitored anesthesia care techniques were excluded.
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IVS. Of these, 178 patients were classiﬁed in propofol-based
sedation group and 20 patients were in non-propofol-based
sedation group. After matching ASA physical status and the
indications of procedure, there were 92PEG procedures in
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Table 1 showed the characteristics of patients, duration
of sedation, and indications of procedure. There were no
statistically signiﬁcant diﬀerences in age, gender, weight,
ASA physical status, sedation time, and indication of the
procedure between the two groups.
Cardiovascular monitoring, including blood pressure
measurements, electrocardiogram, heart rate, and oxygen
saturation, was performed. No premedications were used
before the procedure. All patients were oxygenated with
100% O2 via nasal canular and sedated by well-trained
anesthetic personnel directly supervised by a staﬀ anes-
thesiologist in the endoscopy room. Anesthetic personnel
included residents in anesthesiology and anesthetic nurses
who were well trained in the use of IVS technique and airway
management. All sedated patients were sedated in either
moderate (conscious) or deep sedation level, according to
guideline of the American Society of Anesthesiologists [5].
Subsequently, all cases were concluded with the satisfactory
completion of the procedure.
Table 2 demonstrated overall complication rate, sedation
and procedure related complication, anesthetic personnel,
and mortality rate. Overall, 23 patients (25.0%) in group
A and 4 patients (20.0%) in group B experienced adverse
events.IngroupA,therespiratoryadverseeventsoccurredin
5.4% of patients and comprised 21.7% of all adverse events,
and all of these were under the care of an anesthesiologist.
Interestingly, there were no respiratory adverse events in
group B. Cardiovascular adverse events arose in 18.5% and
20.0% of patients in group A and B, respectively. They
mainly consisted of hypotension (16.3% in group A and
10.0% in group B). One patient in group B developed
hypertension and tachycardia but none in group A. No
procedures were aborted as a result of insuﬃcient sedation
or complications of sedation. In addition, only one patient
in group A developed bleeding after the procedure. In
both groups, IVS was mainly employed by the residents,
and mortality rate was none. However, there were no
signiﬁcant diﬀerences in overall complication rate, sedation
and procedure related complication, anesthetic personnel,
and mortality rate between the two groups.
Table 3 showed the sedative agents used in both groups.
Of these, fentanyl and midazolam were frequently used in
both groups. Mean dose of fentanyl and midazolam in group
A was signiﬁcantly lower than in group B (P = .012 and
<.001, resp.). However, there was not statistical diﬀerence in
the mean dose of ketamine between the two groups (P =
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Table 1: Characteristics of patients, duration of sedation, and indications of procedure (mean, SD and percentage).
Group A Group B P- value
(N = 92) (N = 20)
Age (yr) (mean, SD) 70.3 (8.5) 75.2 (10.7) .376
Gender (%): Male 43 (46.7) 9 (45.0) .888
Female 49 (53.3) 11 (55.0)
Weight (kg) (mean, SD) 49.6 (4.8) 48.1 (6.4) .107
ASA physical status (%): I-II 26 (28.3) 5 (25.0) .768
: III-IV 66 (71.7) 15 (75.0)
Duration of sedation (min) (mean, SD) 25.3 (5.5) 27.3 (7.0) .121
Indication .980
Cerebro-vascular accident 29 (31.5) 7 (35.0)
Dementia 22 (23.9) 5 (25.0)
Oral, larynx and esophageal malignancy 16 (17.4) 3 (15.0)
Prolonged nasogastric tube insertion 8 (8.7) 1 (5.0)
Others 17 (18.5) 4 (20.0)
Group A: propofol-based; Group B: non- propofol based.
Table 2: Overall complication rate, sedation and procedure related complication, anesthetic personnel, and mortality rate (n,% ) .
Group A Group B P-value
(N = 92) (N = 20)
Overall complication rate 23 (25.0) 4 (20.0) .636
Sedation-related complication
Respiratory system 5 (5.4) 0 .286
Hypoxia 2 (2.2) 0 .506
Upper airway obstruction 3 (3.3) 0 .413
Cardiovascular system 17 (18.5) 4 (20.0) .874
Hypotension 15 (16.3) 2 (10.0) .476
Hypertension 0 1 (5.0) .031
∗
Bradycardia 2 (2.2) 0 .506
Tachycardia 0 1 (5.0) .031
∗
Procedure related complication
Bleeding 1 (1.1) 0 .640
Anesthetic personnel .986
Residents 55 (59.8) 12 (60.0)
Anesthetic nurses 37 (40.2) 8 (40.0)
Mortality rate 0 0 1.000
Group A: propofol-based; Group B: non-propofol based.
∗Considered statistically signiﬁcant.
Hemodynamic parameters including systolic and dias-
tolic blood pressure, heart rate, and oxygen saturation
were demonstrated in Table 4. There were not signiﬁcant
diﬀerences between the groups in hemodynamic parameters
at baseline, insertion of endoscope, and at 15, 25, and
30 minutes after scope insertion. However, mean systolic
blood pressure at 5 and 10 minutes after scope insertion, as
well as mean diastolic blood pressure at 5 and 20 minutes,
after scope insertion in the propofol-based group was
signiﬁcantly lower than in the non-propofol-based group.
In addition, mean heart rate at 20 minutes after scope
insertion in the non-propofol-based group was signiﬁcantly
higher than in the propofol-based group. Oxygen saturation
in both groups was over 99% through out the study
period.
4. Discussion
PEG has rapidly replaced surgical gastrostomy as the proce-
dure of choice in virtual patients requiring long-term enteral
nutrition. Increasing numbers of patients are being referred
for PEG placement. PEG can be inserted in the operating
room, endoscopy suite, or at the bedside using IVS. The
overall success rate for PEG placement is rather consistent
at 95% to 98% in all studies, regardless of technique [6–
8]. Procedure-related complications are infrequent (1.5% to4 Gastroenterology Research and Practice
Table 3: Sedative agents used in both groups.
Group A Group B P-value
(N = 92) (N = 20)
Propofol (mg/kg)
N (%) 92 (100.0) 0
Mean (SD) 0.90 (0.20)
Fentanyl (mcg/kg)
N (%) 81 (88.0) 20 (100.0)
Mean (SD) 0.65 (0.19) 0.83 (0.23) .018
∗
Midazolam (mg/kg)
N (%) 74 (80.4) 18 (90.0)
Mean (SD) 0.02 (0.01) 0.03 (0.01) <. 001
∗
Ketamine (mg/kg)
N (%) 6 (6.5) 2 (10.0)
Mean (SD) 0.54 (0.11) 0.79 (0.13) .333
Group A: propofol-based; Group B: non- propofol-based.
∗Considered statistically signiﬁcant.
Table 4: Hemodynamic parameters: systolic and diastolic blood pressure (mmHg), heart rate (beat/minute) and oxygen saturation (SpO2,
%) (mean, SD).
Group A Group B P-value
(N = 92) (N = 20)
Baseline
SBP, DBP 137.3 (18.9), 76.6 (14.1) 139.1 (19.3), 84.6 (11.4) .099, .585
HR, SpO2 73.1 (11.3), 99.3 (1.0) 79.3 (11.0), 99.8 (0.5) .502, .267
At insertion
SBP, DBP 119.3 (18.9), 67.7 (12.8) 124.2 (21.6), 78.5 (15.7) .075, .436
HR, SpO2 70.3 (10.4), 99.8 (0.7) 76.2 (10.9), 100.0 (0.0) .068, .618
5 minutes after insertion
SBP, DBP 113.1 (13.5), 68.1 (12.6) 122.5 (26.3), 76.3 (16.6) .039
∗, .026
∗
HR, SpO2 69.5 (11.1), 99.9 (0.6) 71.1 (16.9), 99.9 (0.2) .226, .887
10 minutes after insertion
SBP, DBP 107.9 (10.4), 67.7 (11.7) 121.4 (27.2), 75.1 (17.9) .035
∗, .476
HR, SpO2 69.2 (11.7), 99.9 (0.6) 75.3 (9.8), 99.9 (0.2) .281, .902
15 minutes after insertion
SBP, DBP 109.9 (10.2), 68.5 (10.4) 119.9 (22.4), 74.6 (13.1) .107, .306
HR, SpO2 70.7 (11.4), 99.9 (0.6) 74.1 (10.7), 100.0 (0.0) .473, .699
20 minutes after insertion
SBP, DBP 110.7 (11.7), 66.5 (11.9) 125.7 (20.2), 78.3 (10.7) .091, .024
∗
HR, SpO2 70.2 (11.5), 99.9 (0.6) 73.7 (10.0), 100.0 (0.0) .031
∗, .817
25 minutes after insertion
SBP, DBP 110.1 (10.6), 70.1 (11.3) 125.2 (18.4), 79.0 (13.4) .097, .297
HR, SpO2 70.7 (12.7), 99.8 (0.9) 76.5 (7.6), 100.0 (0.0) .352, .751
30 minutes after insertion
SBP, DBP 111.9 (10.2), 72.3 (9.4) 117.5 (13.3), 78.3 (7.1) .516, .220
HR, SpO2 69.8 (14.0), 99.9 (0.3) 72.3 (5.4), 99.8 (0.5) .394, .531
Group A: propofol-based; Group B: non-propofol based.
SBP: systolic blood pressure; DBP: Diastolic blood pressure; HR: heart rate; SpO2: oxygen saturation.
∗Considered statistically signiﬁcant.Gastroenterology Research and Practice 5
4.0%)[9,10].However,cardiovascularcomplicationsrelated
to sedation/analgesia are the most frequent complications of
diagnostic endoscopy and PEG procedure [11–13].
Our study showed that the rate of complication during
PEG procedure with or without propofol-based sedation
w a sc o m p a r a b l et oo u rp r e v i o u sr e p o r t s[ 12, 13]. In addi-
tion, the propofol-based sedation does not increase the
complication rate in comparison to the non-propofol-based
sedation (P = .636). However, the complication rate in this
present study is markedly higher than the published study
[11]. One possible explanation of this ﬁnding is that the
number of PEGs underwent IVS technique has remarkably
increased over the last few years. The depth of sedation
in our report was moderate to deep level. Additionally,
this study collected only PEG procedures by using IVS
technique. In that published study [11], upper and lower
gastrointestinal endoscopy procedures done with conscious
(moderate) sedation technique were included the sedation-
related complication rate was 0.54%. However, the previous
series did not mention about the frequently used propofol-
based sedation technique. The result of our study also
demonstrated that the complication rate would be correlated
to the depth of sedation directly. Moreover, the results of
other studies [14–17] also conﬁrmed that patients could
withstand PEG procedure without sedation, and the rate of
complication was fairly low in this technique.
PEG procedure is a minimally invasive one, with low
procedure-related major complications and mortality rates
[10, 18–20]. It is an essential procedure among GI abnor-
mality treatments, even in our institution, where we observe
an increase in number of these procedures every year.
Therefore, it is mandatory to standardize a safe, easy, well-
tolerated anesthesiological procedure, which is feasible in
the GI endoscopy unit. In our previous experiences, we
have noted that topical anesthesia alone is not suﬃcient for
pain-free procedures. In contrast, general anesthesia, which
may be of beneﬁt for the patient and endoscopist comforts,
may be diﬃcult to administer, especially in comorbidity
patients. In addition, the lack of experience in anesthesia
care among endoscopy personnel might increase the risk of
complications.
Propofol, combined with short-acting benzodiazepine,
with or without fentanyl, has already been used in several GI
endoscopic procedures. The present study shows that seda-
tion with or without propofol is safe and well tolerated by
the patient. Furthermore, it is well accepted by endoscopists.
No patients enrolled in the study needed to be resuscitated
during PEG procedure. All patients could be discharged to
the ward within 30 minutes from the end of this procedure,
and this discharge time was not correlated with age, ASA
physical status, and total sedative doses.
Patients were breathing spontaneously; however, oxygen
saturationwasalwaysover99%,andage,ASAphysicalstatus,
and the combination of sedative agents did not negatively
inﬂuence this parameter. Sedation is performed to ensure
the patient’s safety, to minimize physical discomfort or pain,
to provide analgesia and procedural amnesia, to control
behavior during the procedure and to return the patient to
pretreatment level of consciousness. The amount of sedation
required depends on the patient’s physical status and age.
Propofol is widely employed for anesthesia outside the OR
because it is easy to use, has a good safety and eﬃcacy
proﬁle due to its quick onset of action, rapid metabolism,
and signiﬁcantly shorter recovery time, and has some
antiemetic eﬀects [21–23]. Low-dose of midazolam as well as
ketamine, combined with low dose fentanyl and/or propofol,
did not prolong recovery time. Additionally, ketamine in
the company of these agents did not produce emergence
reactions or hallucinations.
The present study used only standard monitoring,
including an assessment of blood pressure, pulse rate, respi-
ratory rate and pulse oximetry, as well as electrocardiogram.
We detected a relatively high overall rate of adverse events
in both groups. This rate is higher than that commonly
reported, and there may be several explanations. We used
these criteria in deﬁning adverse events: hypo/hypertension
and brady/tachycardia measured as the changes of blood
pressure and heart rate of more than 20% of baseline
values. Hypoxia was deﬁned as oxygen saturation <90%.
Hypercapnia (ETCO2 > 50mmHg) could not be detected
directly in this study. Moreover, if only serious adverse events
are included, the adverse event rate is 2.2% in the propofol-
based group and none in the non-propofol-based group.
Interestingly, we found that all respiratory-related adverse
events occurred in the propofol-based group.
In a previous study [24], 151 high risk patients under-
went PEGs (126), and direct jejunostomies (PEJs, 25) were
sedatedbytheuseofanesthesiologist-administeredpropofol.
Minor complications occurred in 25 patients (16.6%): 13
patients (8.6%) fevers, 12 patients (7.9%) systolic blood
pressure drops of >25%, and 1 patient (0.6%) oxygen
desaturation <90%. Major complications occurred in 4
patients (2.6%): 3 patients (2%) aspiration pneumonias and
one patient death (0.6%). We believe that the appropriate
selection of patients for sedation is very important for
everyday practice and will most likely reduce the rate
of adverse events. Finally, the use of pulse oximetry to
monitor hypoxemia is important, especially in cases when
supplemental oxygen is administered.
Data from our previous study [25] showed that sat-
isfaction of both patient and endoscopist about sedated
patients was higher than in nonsedated patients. The use of
sedation was the major determinant of patient satisfaction
and willingness to repeat. Among all of these beneﬁts, it is
advantageous to identify the particular factors that might
encouragepatientstoundergoPEGprocedurewithsedation.
Moreover,thepresentstudyshowedthatPEGprocedurescan
beperformedsafelyandeﬀectivelywithalowercomplication
rate under propofol-based sedation. Additionally, our recent
report [12] also shows that the PEG procedure done with
sedation by well-trained anesthetic personnel is as safe and
eﬀectiveasthatdonewithgeneralanesthesia.Inourhospital,
IVS technique was extensively used for PEG procedures.
However, this is not widespread in the district community
hospitals.
Limitations of this study exist. First, there is the wide
range in age of the patients in our study. Drug requirements
and adverse events can be related to patient’s age. Second,6 Gastroenterology Research and Practice
inaccurate and incomplete documentation of certain mea-
sures, as occured with many chart reviews, also occurred
in this study. Third, the limitation of monitoring, such as
of end-tidal carbon dioxide, could result in a lower rate
of adverse events. Overall, despite these limitations, we are,
however, conﬁdent that these ﬁndings are generalizable to
the practice of PEG procedure using any type of sedation.
Finally, because the serious complications in our series were
low, further studies in larger prospective groups of patients
are therefore needed.
In conclusion, we report the performance of the clinical
eﬃcacy of sedation with or without propofol regimen utiliz-
inganesthesiologistoranesthetic personnelwithappropriate
basic monitoring for PEG procedure in a unit outside OR
from a tertiary-care teaching hospital in Thailand. The
ﬁndings of the present study show that propofol-based
sedation does not increase rate of complication during PEG
procedure. IVS of PEG procedure is relatively safe and
eﬀective when performed by physicians in training. Serious
complications are none. We hope that our practice will help
modeling the development of IVS for PEG procedure in the
community hospitals in Thailand.
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